Syed R Ahmad

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi Renal failure associated with the use of celecoxib and rofecoxib
    Syed R Ahmad
    Division of Drug Risk Evaluation, Office of Drug Safety, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, USA
    Drug Saf 25:537-44. 2002
  2. ncbi Adverse drug event monitoring at the Food and Drug Administration
    Syed Rizwanuddin Ahmad
    Division of Drug Risk Evaluation, Office of Drug Safety, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD 20857, USA
    J Gen Intern Med 18:57-60. 2003
  3. ncbi Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States
    Parivash Nourjah
    Office of Drug Safety, Division of Drug Risk Evaluation, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Pharmacoepidemiol Drug Saf 15:398-405. 2006
  4. ncbi Safety of recommended doses of paracetamol
    Syed Rizwanuddin Ahmad
    Lancet 369:462-3. 2007
  5. ncbi Pneumonitis with antiandrogens
    Syed Rizwanuddin Ahmad
    Ann Intern Med 139:528-9; author reply 529. 2003

Detail Information

Publications5

  1. ncbi Renal failure associated with the use of celecoxib and rofecoxib
    Syed R Ahmad
    Division of Drug Risk Evaluation, Office of Drug Safety, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, USA
    Drug Saf 25:537-44. 2002
    ..The nephrotoxic potential of selective COX-2 inhibitors has not been clearly established. This study was conducted in order to understand the association between acute renal failure and the two COX-2 inhibitors celecoxib and rofecoxib...
  2. ncbi Adverse drug event monitoring at the Food and Drug Administration
    Syed Rizwanuddin Ahmad
    Division of Drug Risk Evaluation, Office of Drug Safety, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD 20857, USA
    J Gen Intern Med 18:57-60. 2003
    ..The FDA is strengthening its postmarketing surveillance with access to new data sources that have the potential to further improve the identification, quantification, and subsequent management of drug risk...
  3. ncbi Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States
    Parivash Nourjah
    Office of Drug Safety, Division of Drug Risk Evaluation, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Pharmacoepidemiol Drug Saf 15:398-405. 2006
    ..To estimate the number of acetaminophen-associated overdoses in the United States and identify possible risk factors for intervention...
  4. ncbi Safety of recommended doses of paracetamol
    Syed Rizwanuddin Ahmad
    Lancet 369:462-3. 2007
  5. ncbi Pneumonitis with antiandrogens
    Syed Rizwanuddin Ahmad
    Ann Intern Med 139:528-9; author reply 529. 2003